GROW MORE, INC. – Trademark Portfolio
Entity Type: 03
GROW MORE, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include PHOS PRO, GROW MORE, BIO-COZYME, and MENDOCINO PRODUCER'S CHOICE. The owner is based in GRADENA, CA.
15600 NEW CENTURY DRIVE
GRADENA, CA 90248
Showing of trademarks Trademarks
Trademark Classifications
GROW MORE, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does GROW MORE, INC. have?
GROW MORE, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned, 3 cancelled.
What trademark classes does GROW MORE, INC. file in?
GROW MORE, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are GROW MORE, INC.'s most well-known trademarks?
GROW MORE, INC.'s registered trademark portfolio includes well-known marks such as PHOS PRO, GROW MORE, BIO-COZYME, and MENDOCINO PRODUCER'S CHOICE. These are among 5 currently registered trademarks in the portfolio.
What is GROW MORE, INC.'s trademark registration success rate?
GROW MORE, INC. has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.